3D Printing Microstructures for New Drug Delivery Systems with SPHRINT

RAPID

Share this Article

In the recently published, ‘SPHRINT – Printing Drug Delivery Microspheres from Polymeric Melts,’ authors Tal Shpigel, Almog Uziel, and Dan Y. Lewitus explore better ways to offer sustained release pharmaceuticals via 3D printed structures.

Currently, numerous materials are used to create microparticles for sustained drug release, with numerous choices in biodegradable materials, such as include poly(lactic acid) (PLA), polyglycolic acid (PGA), their copolymer poly(lactic-co-glycolic) acid (PLGA) and polycaprolactone.

“Numerous microparticle-based depots products are FDA approved, amongst them are: Zmax® (Azithromycin), Decapeptyl®/Trelstar® (Triptorelin), Vivitrol® (Naltrexone), Arestin® (Minocycline), Risperdal® Consta® (Risperidone), Sandostatin® LAR Depot (Octreotide), Nutropin Depot® (Somatropin), Lupron Depot® (Leuprolide), DepoCyt® (Cytarabine), DepoDur® (Morphine), Bydureon® (Exenatide) Somatuline LA (Lanreotide) [1] and recently approved ZILRETTA™ (triamcinolone acetonide),” state the authors.

Frames obtained from high-speed imaging capturing the evolution of the shape of a molten 30% IBU-PCL blend interacting with either a superoleophobic surface (top) and preserving its spherical shape after 1.8 s or an aluminum surface (bottom), in which the droplet gradually flattens (See SI Video 4 and SI Video 5, respectively). Scale bar: 500 µm. These frames emphasis the significance of using non-wetting surfaces responsible for the formation of spherical droplets.

With the advent of 3D printing and inkjet technology, researchers have experimented with numerous techniques. Many have encountered obstacles though, and challenges regarding methods relying on both inkjet printing and those that are solvent based. Because of that, the researchers created an affordable, yet solvent-free technique for fabricating polymer melts in this study—showing the capability of their SPHRINT technique.

(A) Optical images of (i) neat PCL (154 ± 3°), (ii) 30% IBU-PCL (171 ± 4°), (iii) neat PLGA (167 ± 6°), and (iv) 30% IBU-PLGA (169 ± 4°) microspheres, cooled at room temperature (RT). The values in brackets denote the “sphericity,” expressed as the contact angle values (mean ± S.E.M., n = 10). Scale bar: 200 µm. (B) SEM images of (i) 30% IBU-PCL and (ii) 30% IBU-PLGA microspheres, cooled at RT. Scale bars: 100 µm

Producing drug delivery microspheres from a polymer loaded with a sample drug like ibuprofen, the researchers experimented and conducted an analysis regarding the potential for fabrication of amorphous polymeric microspheres. The researchers evaluated microsphere size, morphology, and texture. Ultimately, they were able to produce ‘near-perfect microspheres.’

“We discovered intricate physical phenomena governing the mechanism of sphere-formation; beside process and performance efficiencies, which in turn render microsphere products more accessible,” stated the researchers. “SPHRINT printing eliminates the use of organic solvents and surfactants; it offers microspheres with reproducible size, shape, and morphology within and between the batches; and the produced microspheres can be easily collected owing to their spherical shape.”

Jetting rate and shear rate were calculated, along with an investigation of melt interaction with the superoleophobic substrate and sphere formation.

In terms of drug encapsulation efficiency, they found that values in connection with SPHRINT were on the highest scale. The authors were encouraged to find ‘stable, consistent, reproducible results.’

“… we believe that SPHRINT may turn microsphere production ubiquitous, allowing for desktop manufacturing of microspheres easily scalable to industrial quantities (with a production rate of 25 Hz, in 1 h, 4.7 g of PCL microspheres may be printed from a single printing head). Finally, SPHRINT may provide a new dimension in reservoir-injectable drug delivery technologies, enabling the employment of multifarious polymers for microsphere production and tuned release profiles,” concluded the researchers.

3D printing has been used in connection with a variety of different drug delivery systems, from experimenting with microreservoirs to hydrophilic matrices, and even spermbots. What do you think of this news? Let us know your thoughts; join the discussion of this and other 3D printing topics at 3DPrintBoard.com.

[Source / Images: ‘SPHRINT – Printing Drug Delivery Microspheres from Polymeric Melts’]

Share this Article


Recent News

3D Printing Serves as a Bridge to Mass Production in New Endeavor3D White Paper

3DPOD Episode 200: Joris and Max Wax Philosophic on Five Years of Podcasting



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Featured

Printing Money Episode 18: The DC Fly-In with Mark Burnham, AddMfgCoalition

It’s only been a week since the previous show, but Printing Money is back already with Episode 18. Certain events call for Printing Money’s coverage, and the recent 2nd Annual...

3DPOD Episode 199: Collaborative Design with Graham Bredemeyer, CEO of CADchat

About a decade ago, entrepreneur Graham Bredemeyer started Collider, a company that combined the best of 3D printing with injection molding. Now he runs CADChat, which hopes to make sharing...

Printing Money Episode 17: Recent 3D Printing Deals, with Alex Kingsbury

Printing Money is back with Episode 17!  Our host, NewCap Partners‘ Danny Piper, is joined by Alex Kingsbury for this episode, so you can prepare yourself for smart coverage laced...

3DPOD Episode 198: High Speed Sintering with Neil Hopkinson, VP of AM at Stratasys

Neil Hopkinson, a pioneering 3D printing researcher, played a pivotal role in developing a body of research that is widely utilized today. He also invented High Speed Sintering (HSS), also...